(Q38112387)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

meta-analysis

0 references

title

Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

main subject

arterial hypertension

0 references

systematic review

1 reference

based on heuristic

inferred from title

pulmonary hypertension

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Guillaume Lefevre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Luc Dauchet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Éric Hachulla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Vincent Sobanski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Marc Lambert

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Marc Humbert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

David Launay

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

7

Pierre-Yves Hatron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

1 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

2412-2423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23740572%20AND%20SRC:MED&resulttype=core&format=json

Systemic sclerosis-associated pulmonary arterial hypertension

2 March 2020

cites work

1 reference

Changes in causes of death in systemic sclerosis, 1972-2002

21 January 2018

1 reference

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

Guidelines for the diagnosis and treatment of pulmonary hypertension.

21 January 2018

1 reference

Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease

21 January 2018

1 reference

ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre.

21 January 2018

1 reference

Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease

21 January 2018

1 reference

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

21 January 2018

1 reference

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype

21 January 2018

1 reference

Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.

21 January 2018

1 reference

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

21 January 2018

1 reference

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol.

21 January 2018

1 reference

Is pulmonary arterial hypertension really a late complication of systemic sclerosis?

21 January 2018

1 reference

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study

21 January 2018

1 reference

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

21 January 2018

1 reference

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

21 January 2018

1 reference

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

21 January 2018

1 reference

Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases

21 January 2018

1 reference

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

21 January 2018

1 reference

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

21 January 2018

1 reference

Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol

21 January 2018

1 reference

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

21 January 2018

1 reference

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival

21 January 2018

1 reference

Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus

21 January 2018

1 reference

Development of prognostic tools in pulmonary arterial hypertension: lessons from modern day registries.

21 January 2018

1 reference

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

21 January 2018

1 reference

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

21 January 2018

1 reference

The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension.

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective

21 January 2018

1 reference

Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.

21 January 2018

1 reference

Pulmonary hypertension in COPD.

21 January 2018

1 reference

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome

21 January 2018

1 reference

Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.

21 January 2018

1 reference

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

21 January 2018

1 reference

Survivor bias and risk assessment

21 January 2018

1 reference

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

21 January 2018

1 reference

Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group

21 January 2018

1 reference

Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis.

21 January 2018

1 reference

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.

21 January 2018

1 reference

Survival in primary pulmonary hypertension: the impact of epoprostenol therapy.

21 January 2018

1 reference